AzTrials
AzTrials

Transtibial Amputation - UnilateralNCT05964855

Comparison of Various Prosthetic Foot-Ankle Mechanisms

A study testing MIT Variable Stiffness Prosthesis v1, MIT Variable Equilibrium Angle Prosthesis v1 and MIT Sliding Beam Passive Prosthesis in people with Transtibial Amputation - Unilateral, run by Massachusetts Institute of Technology at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In summary, subjects will be asked to wear a number of sensors and use different ankle-foot prostheses in place of their customary prosthesis. Data will be collected from the wearable sensors, VICON motion capture system, video cameras, and force sensors in the ground as they walk on level-ground, on a treadmill, and… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Transtibial Amputation - Unilateral
What is being tested?
MIT Variable Stiffness Prosthesis v1, MIT Variable Equilibrium Angle Prosthesis v1 and MIT Sliding Beam Passive Prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
2 sitesUnited States
Study dates
28 Jul 2023to 1 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Person with unilateral transtibial amputation
  • K3 or K4 Medicare mobility rating
  • Ages 18-65

Who cannot join

  • Below K3 Medicare mobility rating
  • Outside of age range (liability and safety reasons)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • A Step Ahead Prosthetics

    Burlington, Massachusetts, 01803

  • MIT Media Laboratory

    Cambridge, Massachusetts, 02139

Other trials in United States

About this study

In summary, subjects will be asked to wear a number of sensors and use different ankle-foot prostheses in place of their customary prosthesis. Data will be collected from the wearable sensors, VICON motion capture system, video cameras, and force sensors in the ground as they walk on level-ground, on a treadmill, and on stairs. The controller of any powered prosthesis will be electronically adjusted between trials or while the subject walks to determine how their gait changes in response to these changes. Trials will also be conducted with a standard passive prosthesis that would be prescribed for a person of similar height and weight.

Read the detailed description

Subject Selection and Consent:

Subjects will be selected based on the following priority. Subjects who have previously participated in similar studies with the Biomechatronics lab and who have already been screened for health and mobility level will be contacted first. If additional subjects are needed, a recruitment flyer and screening questionnaire will be sent to potential candidates. Copies of both the flyer and questionnaire are included in the attachments section. Prior to the experimental sessions, subjects will be asked to read and sign a informed consent form and will explain the project to them and answer any questions that they may have. They will also be given time to become familiar with the equipment being used before beginning any trials. If needed, subjects will be aligned and fitted by a professional prosthetist at A Step Ahead Prosthetics in Burlington, MA. No personnel at A Step Ahead Prosthetics will conduct research or have any vested interest in research outcomes or publication.

Attire:

Subjects will be asked to wear tight-fitting clothes, such as a skin-tight shirt, running shorts and low-profile shoes. If this is not possible, clothes will be provided according to subject needs. The investigators will provide and may require subjects to wear a skin-tight Velcro outfit that allows us to place reflective balls for video camera capture.

Location(s) and Timeline:

Experimental sessions will be conducted in the MIT Biomechatronics Laboratory (E14-274), 75 Amherst St., Cambridge, MA 02139 and the basement connecting MIT Building 66, 68, and E19 (31 Ames St., Cambridge, MA 02139). The basement is a publicly accessible area, and visible signage will be posted to alert passerby. Any alignment and fitting of prosthetic devices will take place at either the aforementioned location or at A Step Ahead Prosthetics, 21 A. St., Burlington, MA 01803 by a trained prosthetist.

Total study duration is expected to be 8 hours per subject, likely over two 4-hour sessions. These sessions can be completed either in a single day or over two days.

Powered Prosthesis:

Subjects will be given three or four computer-controlled quasi-passive (QP) ankle-foot prostheses to attach in place of their customary prosthesis during a session, depending on the arm. These include the Blatchford Elan, Ossur Proprio, a variable-stiffness prosthesis (VSA), and a variable-angle prosthesis (VAA). These QP prostheses have the capability of providing active assistance or changing mechanical properties during walking. Controls will be adjusted either through a wireless link or hardwire connection depending on the device. Subjects will be given as much time as necessary to practice using the prostheses before the experiments begin.

Passive Prosthesis:

Subjects will be given 1-3 passive prostheses to attach in place of their customary prosthesis during a session. These include the Ossur Pro-Flex XC and a passive sliding-beam prosthesis based on the Variable Stiffness prosthesis above with the electronics and actuator removed. In the first arm, a passive prosthesis that can change ankle equilibrium angle manually will be used. Subjects will be given as much time as necessary to practice using the prosthesis before the experiments begin.

Data Collection:

Data collection is expected to take place in two segments. In the first segment, each subject will walk on a treadmill at three speeds between 0.5-1.5m/s (slow to fast walking), chosen based on their comfort. At each speed, all five prostheses will be tested, randomly selected, for 2mins each. Motion will be captured with a VICON motion capture system, and ground reaction forces will be measured using a Bertec force-sensitive treadmill. For each speed, once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis performed at heel strike (early stance), roll over (mid stance), and powered plantar flexion (late stance). In addition, each subject will be asked how each prosthesis generally performed, and their personal preference. This testing will occur across the three walking speeds, resulting in three completed questionnaires.

In addition, subjects will walk in a figure-8 pattern at a preferred gait speed around two cones placed on the level-ground walking surface and separated by up to 30 feet. Handrails and a harness will be available to the subject as needed. Subjects will perform the walking figure-8 for a minimum of 5 times for each randomly-selected prosthesis. Once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis generally performed, and their personal preference.

Each subject will ascend and descend stairs and a ramp inclined between 4°-8° from horizontal at their preferred speed, in a randomly selected order. This incline is akin to between an ADA-compliant wheelchair ramp and a moderately inclined hill. Motion will be captured with a VICON motion capture system, and ground reaction forces will be measured using a Bertec force-sensitive treadmill for slope ambulation, and a force-sensitive staircase for stair ambulation. All five prostheses will be tested, randomly selected. Subjects will perform each of stair ascent and stair descent for a minimum of 5 times per prosthesis. For slopes and stairs, subjects will be asked to test different stiffnesses and angles and pick a preferred setting for the VSA and VAA, respectively. Data will be collected for a total of 2mins for slope ascent and 2mins for slope descent with each prosthesis. If necessary, subjects will test up to 5 ankles on an ADA-compliant over-ground ramp for additional slope ascent and slope descent evaluation. This will provide additional evaluation of differences between treadmill and over-ground slope walking for both subject and researcher. Subjects will walk up and down the ramp a minimum of 5 times per prosthesis. Handrails are available along the entire ramp, and a researcher will be beside the subject for assistance. For each slope and stair ascent/descent, once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis generally performed, and their personal preference. This testing will occur across the slope terrain types, as well as after the stair ascent/descent trial, resulting in three completed questionnaires for each subject. If time allows, subjects may also be asked to test test up to 5 ankles a 30 ft. over-ground course consisting of level-ground, stairs, and slopes in order to evaluate transitions between terrains. Subjects will perform the course a minimum of 3 times. This will not be evaluated via questionnaire and is meant to provide information to the researcher on future prosthetic design. Handrails are available for all elements except an adjustable ramp, for which a researcher will be beside the subject for assistance.

Being tested
MIT Variable Stiffness Prosthesis v1, MIT Variable Equilibrium Angle Prosthesis v1, MIT Sliding Beam Passive Prosthesis, Ossur Pro-Flex XC, Blatchford Elan Variable-Dampening Prosthesis
Keywords
Foot-ankle device, prosthesis, mobility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MIT Variable Stiffness Prosthesis v1Device

    Also called VS, VSA

    Proprietary electronically-controlled prosthesis that can vary its effective stiffness.

  • MIT Variable Equilibrium Angle Prosthesis v1Device

    Also called VA, VAA

    Proprietary manually-controlled prosthesis that can vary its effective ankle equilibrium angle.

  • MIT Sliding Beam Passive ProsthesisDevice

    Also called SB

    Proprietary fixed-stiffness passive foot-ankle prosthesis.

  • Ossur Pro-Flex XCDevice

    Also called Pro-Flex XC, XC, PF

    Commercially-available passive fixed-stiffness foot-ankle prosthesis by Ossur.

  • Blatchford Elan Variable-Dampening ProsthesisDevice

    Also called Elan, EL

    Commercially-available electronically-controlled prosthesis that can vary its effective dampening.

  • Ossur Proprio Variable Angle ProsthesisDevice

    Also called Proprio, PP

    Commercially available variable ankle angle prosthesis by Ossur.

  • MIT Variable Stiffness Prosthesis v2Device

    Also called Folia, VS, VSA

    Second generation a proprietary electronically-controlled prosthesis that can vary its effective stiffness.

  • MIT Variable Equilibrium Angle Prosthesis v2Device

    Also called VA, VAA

    Second generation prototype prosthesis that can vary its effective ankle equilibrium angle.

Study groups in NCT05964855
Study groupRoleWhat they receive
Evaluation of first generation prototype prosthesesExperimentalClinical trial to evaluate efficacy of first generation of MIT prototype prosthetic ankle-foot devices on people with unilateral transtibial amputation over different walking speeds and terrains.
Receives: Device: MIT Variable Stiffness Prosthesis v1; Device: MIT Variable Equilibrium Angle Prosthesis v1; Device: MIT Sliding Beam Passive Prosthesis; Device: Ossur Pro-Flex XC; Device: Blatchford Elan Variable-Dampening Prosthesis
Evaluation of second generation of prototype prosthesesExperimentalClinical trial to evaluate efficacy of second generation of MIT prototype prosthetic ankle-foot devices on people with unilateral transtibial amputation over different walking speeds and terrains.
Receives: Device: Ossur Pro-Flex XC; Device: Blatchford Elan Variable-Dampening Prosthesis; Device: Ossur Proprio Variable Angle Prosthesis; Device: MIT Variable Stiffness Prosthesis v2; Device: MIT Variable Equilibrium Angle Prosthesis v2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. User device preference for level-ground walking

    Determine which device the users prefer for level-ground walking by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  2. User device preference for stair ascent & descent

    Determine which device the users prefer for stair ascent \& descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  3. User device preference for sloped ground ascent & descent

    Determine which device the users prefer for 8-degree sloped ground ascent \& descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Secondary outcomes (4)
  1. Effect of device on level-ground walking gait

    Evaluate the effect of the device on level-ground walking gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  2. Effect of device on stair ascent & descent gait

    Evaluate the effect of the device on stair ascent and descent gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  3. Effect of device on sloped ground walking gait

    Evaluate the effect of the device on sloped ground walking gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  4. Effect of device on ground reaction force during ambulation

    Evaluate the effect of the device on ground reaction forces during ambulation. Ground reaction forces will be measured with Bertec force plates. Unit of measure is ground reaction force in Newtons.

    Measured: From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2023
  2. Study start28 Jul 2023
  3. Primary completion1 Apr 2026
  4. Study completion1 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05964855
Sponsor's protocol ID
2306001029
Status last verified
Aug 2026
First submitted
11 Jul 2023
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing MIT Variable Stiffness Prosthesis v1, MIT Variable Equilibrium Angle Prosthesis v1 and MIT Sliding Beam Passive Prosthesis in people with Transtibial Amputation - Unilateral, run by Massachusetts Institute of Technology at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

User device preference for level-ground walking (time frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in